annual total liabilities:
$52.27M-$24.47M(-31.89%)Summary
- As of today (September 17, 2025), CDTX annual total liabilities is $52.27 million, with the most recent change of -$24.47 million (-31.89%) on December 31, 2024.
- During the last 3 years, CDTX annual total liabilities has fallen by -$2.03 million (-3.74%).
- CDTX annual total liabilities is now -31.89% below its all-time high of $76.74 million, reached on December 31, 2023.
Performance
CDTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$33.15M-$16.89M(-33.75%)Summary
- As of today (September 17, 2025), CDTX quarterly total liabilities is $33.15 million, with the most recent change of -$16.89 million (-33.75%) on June 30, 2025.
- Over the past year, CDTX quarterly total liabilities has dropped by -$9.27 million (-21.85%).
- CDTX quarterly total liabilities is now -56.80% below its all-time high of $76.74 million, reached on December 31, 2023.
Performance
CDTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CDTX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | -21.9% |
| 3 y3 years | -3.7% | -30.2% |
| 5 y5 years | +67.8% | +3.4% |
CDTX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.9% | at low | -56.8% | at low |
| 5 y | 5-year | -31.9% | +67.8% | -56.8% | +3.4% |
| alltime | all time | -31.9% | +3168.9% | -56.8% | +970.9% |
CDTX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $33.15M(-33.8%) |
| Mar 2025 | - | $50.05M(-4.3%) |
| Dec 2024 | $52.27M(-31.9%) | $52.27M(+11.9%) |
| Sep 2024 | - | $46.70M(+10.1%) |
| Jun 2024 | - | $42.42M(-39.8%) |
| Mar 2024 | - | $70.50M(-8.1%) |
| Dec 2023 | $76.74M(+23.1%) | $76.74M(+38.4%) |
| Sep 2023 | - | $55.43M(+5.4%) |
| Jun 2023 | - | $52.57M(-4.2%) |
| Mar 2023 | - | $54.90M(-12.0%) |
| Dec 2022 | $62.36M(+14.8%) | $62.36M(+7.9%) |
| Sep 2022 | - | $57.79M(+21.7%) |
| Jun 2022 | - | $47.48M(-5.7%) |
| Mar 2022 | - | $50.34M(-7.3%) |
| Dec 2021 | $54.30M(+9.2%) | $54.30M(+3.7%) |
| Sep 2021 | - | $52.36M(+9.2%) |
| Jun 2021 | - | $47.95M(-8.3%) |
| Mar 2021 | - | $52.32M(+5.2%) |
| Dec 2020 | $49.71M(+59.6%) | $49.71M(+45.7%) |
| Sep 2020 | - | $34.12M(+6.4%) |
| Jun 2020 | - | $32.05M(+5.6%) |
| Mar 2020 | - | $30.34M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $31.14M(+55.9%) | $31.14M(-4.9%) |
| Sep 2019 | - | $32.73M(+63.9%) |
| Jun 2019 | - | $19.97M(-2.4%) |
| Mar 2019 | - | $20.45M(+2.4%) |
| Dec 2018 | $19.97M(+3.5%) | $19.97M(-12.7%) |
| Sep 2018 | - | $22.88M(-8.0%) |
| Jun 2018 | - | $24.87M(+28.7%) |
| Mar 2018 | - | $19.33M(+0.2%) |
| Dec 2017 | $19.29M(+2.7%) | $19.29M(+14.4%) |
| Sep 2017 | - | $16.86M(-15.2%) |
| Jun 2017 | - | $19.89M(+18.6%) |
| Mar 2017 | - | $16.77M(-10.7%) |
| Dec 2016 | $18.78M(+209.8%) | $18.78M(+125.8%) |
| Sep 2016 | - | $8.32M(+59.5%) |
| Jun 2016 | - | $5.21M(+25.8%) |
| Mar 2016 | - | $4.14M(-31.6%) |
| Dec 2015 | $6.06M(+86.7%) | $6.06M(+38.9%) |
| Sep 2015 | - | $4.36M(+40.9%) |
| Jun 2015 | - | $3.10M(-19.4%) |
| Mar 2015 | - | $3.84M(+18.3%) |
| Dec 2014 | $3.25M(+103.1%) | $3.25M |
| Dec 2013 | $1.60M | - |
FAQ
- What is Cidara Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Cidara Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of CDTX is $52.27M
What is the all time high annual total liabilities for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual total liabilities is $76.74M
What is Cidara Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, CDTX annual total liabilities has changed by -$24.47M (-31.89%)
What is Cidara Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of CDTX is $33.15M
What is the all time high quarterly total liabilities for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly total liabilities is $76.74M
What is Cidara Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, CDTX quarterly total liabilities has changed by -$9.27M (-21.85%)